Heather Arnett

Heather is leading research discovery and development at NuMedii, successfully translating AI hits into novel therapeutics. She has more than 15 years of experience in large and small molecule drug discovery and development, and more than 30 publications in top-tier journals with research focused on diverse pathways in immunology, neuroscience, and fibrotic diseases. In her most recent role at Amgen, Heather spearheaded multiple immune-modulatory therapies, as well as building and managing a robust team of scientists and associates focused on filling the pipeline with new therapies for fibrotic and inflammatory diseases, and immuno-oncology. She holds a Ph.D. in Neuroscience from the University of North Carolina at Chapel Hill and completed a National Multiple Sclerosis Society postdoctoral fellowship at Harvard Medical School and the Dana-Farber Cancer Institute.